Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis
Takeya Sugimoto, Daichi Fujimoto, Yuki Sato, Motohiro Tamiya, Takashi Yokoi, Yoshihiko Taniguchi, Aoi Hino, Akito Hata, Junji Uchida, Yasushi Fukuda, Satoshi Hara, Masaki Kanazu, Hirotaka Matsumoto, Masaki Kokubo, Nobuyuki Yamamoto
Topics & Concepts
DurvalumabMedicinePneumonitisChemoradiotherapyInternal medicineHazard ratioLung cancerRadiation therapyStage (stratigraphy)Prospective cohort studyOncologyCancerSurgeryConfidence intervalLungImmunotherapyPaleontologyBiologyNivolumabCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment